We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Featured News

 

Latest News

Symphogen’s Success Attracts USD 25 Million Investment
News   Jan 12, 2006

The financing will be used to carry out clinical trials of Symphogen’s first product, anti-RhD.

READ MORE

Strand and ChemAxon Enter into Collaboration
News   Jan 12, 2006

Strand Life Sciences integrates ChemAxon’s JChem suite of software with admetis.

READ MORE

Several new Pharma Drug Delivery Evaluation Agreements for pSivida
News   Jan 12, 2006

pSivida has entered into agreements to evaluate its platform technology for pharmaceutical companies’ developmental compounds.

READ MORE

Scientists Make First Step Towards 'Holy Grail' of Crystallography
News   Jan 12, 2006

Scientists develop a theory concerning the design of porous materials for protein crystallization.

READ MORE

Roche and Amira Pharmaceuticals Announce Innovative Alliance Model
News   Jan 12, 2006

Research collaboration for targets in inflammatory diseases; option for Amira to license specified clinical compounds from Roche.

READ MORE

Researcher Discovers Antidepressant Protein in Mouse Brain
News   Jan 12, 2006

Researchers found that p11 appears to help regulate signaling of the brain messenger chemical serotonin.

READ MORE

Qiagen and Eppendorf Collaborate to Development and Marketing of Life Science Solutions
News   Jan 12, 2006

Qiagen to acquire Eppendorf's nucleic acid sample preparation kit and PCR reagent business.

READ MORE

Partek Achieves Affymetrix GeneChip-Compatible™ Status
News   Jan 12, 2006

Partek has achieved Affymetrix GeneChip-compatible™ status in Gene Expression, Exon Expression, and SNP Copy Number analysis.

READ MORE

Ocimum Ranks 55th in Deloitte Technology Fast 500 Asia-Pacific 2005
News   Jan 12, 2006

Ocimum also has the distinction of scoring 4th rank in the Deloitte Technology Fast 50 India 2005 Award.

READ MORE

Morphotek Divests Cell Evolution Service Business to Invitrogen
News   Jan 12, 2006

This divestment allows Morphotek to focus its business strategy on advancing its therapeutic antibody pipeline.

READ MORE